Search For "immunotherapy drugs"
Patients with high-risk local melanomas benefit from immunotherapy drug: S
Updated : 4 years, 5 months ago IST
Pennsylvania [US], September 20 (ANI): According to the results of an international, randomized phase III clinical trial led by UPMC Hillman Cancer Center, immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage IIb and IIc melanoma.
Read More
Study shows stem-like T cells could aid immunotherapy in cancer treatment
Updated : 4 years, 6 months ago IST
Washington [US], September 3 (ANI): In a new study by Yale Cancer Center, researchers show stem-like T cells within certain lymph nodes could be natural cancer fighters. Targeting these T cells, which are a type of white blood cells, with immunotherapy drugs could increase the number of canc
Read More
Immunotherapy drugs are riskier for treatment of cancer patients, study su
Updated : 5 years, 3 months ago IST
Washington [US], December 13 (ANI): A study published in the European Heart Journal, found that the risks of heart problems in cancer patients are higher if they are treated with immunotherapy drugs, which can even lead to death from heart attack.
Read More
Study reveals cancer patients receiving immunotherapy drugs have a higher
Updated : 5 years, 3 months ago IST
Washington [US], December 9 (ANI): A study of over a thousand cancer patients treated with immunotherapy drugs has found these patients are at greater risk of heart problems, including death from a heart attack or stroke.
Read More
Immunotherapy drugs when combined prevent melanoma progression
Updated : 6 years, 5 months ago IST
Washington D.C. [USA], Sept 29 (ANI): In a new trial, researchers have discovered that a combination of two immunotherapy drugs -- ipilimumab and nivolumab - is capable of reversing or preventing the progression of advanced melanoma for five years or more in one in every two patients.
Read More
Immunotherapy combination shrinks rare, neuroendocrine cancer: study
Updated : 6 years, 11 months ago IST
Washington D.C. [USA], Apr 1 (ANI): Scientists have found that rare and aggressive neuroendocrine tumours shrink through a combination of two common immunotherapy drugs.
Read More